Nancy Weaver | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Nancy Weaver | Health Professions | Best Researcher Award

Saint Louis University | United States

Author Profile

Scopus

Google Scholar

🎓 Early Academic Pursuits

Dr. Nancy Weaver's academic journey is a testament to her commitment to public health and data-driven decision-making. She earned her Ph.D. in Health Behavior and Health Education from the University of North Carolina at Chapel Hill in 2004, solidifying her expertise in behavioral sciences. Prior to this, she completed her Master of Public Health (MPH) in Biostatistics in 1995 at the same institution, honing her skills in data analysis and health research. Her foundation in quantitative sciences began with a Bachelor of Science in Mathematics, complemented by a minor in Statistics, from James Madison University in 1990. These academic achievements laid a strong groundwork for her future contributions to public health research and policy.

🌟 Professional Endeavors

Dr. Weaver has built an illustrious career as a leader in health behavior research and community engagement. She currently serves as a tenured Professor at the College for Public Health and Social Justice, Department of Behavioral Science and Health Education at Saint Louis University. Additionally, she co-directs the Community Engagement Core at the Center for Innovation in Child Maltreatment at Washington University in St. Louis, showcasing her dedication to interdisciplinary collaboration. Beyond academia, she is the Founder and CEO of Support Over Silence, LLC, an initiative focused on empowering individuals to respond to distress in public settings. She also operates Weaverly Consulting, LLC, where she provides strategic guidance in public health programs. Throughout her career, she has held numerous leadership positions, including Associate Dean for Academic and Faculty Affairs and Founding Operations Director of the Research and Equity in Action for Child Health (REACH) Center. Her career trajectory underscores her unwavering dedication to improving health education and policy.

📈 Contributions and Research Focus

Dr. Weaver’s research is centered on child maltreatment prevention, health literacy, and behavioral interventions. She has secured substantial research funding, including her role as a subcontract principal investigator for the Center for Innovation in Child Maltreatment Policy, Research, and Training, a multi-million-dollar initiative backed by the National Institute of Child Health and Human Development. Her work has also extended to projects funded by the Centers for Disease Control and Prevention (CDC), where she has led efforts to tailor injury prevention communications for parents and healthcare providers. Her research contributions have significantly influenced pediatric injury prevention, as evidenced by her involvement in projects aimed at integrating injury prevention into home visitation programs and developing communication strategies for public health initiatives. She has also played a key role in addressing child maltreatment through social marketing and bystander intervention models, ensuring that her research translates into actionable public health solutions.

🏆 Accolades and Recognition

Dr. Weaver’s contributions to public health have been widely recognized through various grants and prestigious appointments. Her work in injury prevention and health communication has been published in top-tier journals such as the American Journal of Sports Medicine, Pediatrics, and Health Promotion Practice. Her research has also garnered attention for its practical applications, with her tailored communication strategies being implemented in pediatric primary care settings. As a mentor and educator, she has played a crucial role in training the next generation of public health professionals, further amplifying her impact on the field.

🌍 Impact and Influence

Dr. Weaver’s influence extends beyond academia into policy-making and community advocacy. Through her research, she has shaped national discussions on child safety and health literacy. Her work in developing evidence-based interventions has informed policy decisions at both state and national levels, demonstrating the real-world impact of her academic endeavors. She has also been instrumental in bridging the gap between social sciences and medical research, ensuring a holistic approach to health behavior interventions. Her collaborations with organizations like the Missouri Foundation for Health and the National Cancer Institute highlight her commitment to multidisciplinary problem-solving.

🌟 Legacy and Future Contributions

As a leader in public health education and research, Dr. Nancy Weaver’s legacy is built on her dedication to improving child and community health outcomes. Her work continues to inspire new approaches to health behavior interventions, with a strong emphasis on data-driven strategies and community engagement. Through her roles in academia, consultancy, and nonprofit initiatives, she is paving the way for innovative solutions to pressing public health challenges. Her ongoing research in child maltreatment prevention, injury risk reduction, and health communication will undoubtedly leave a lasting imprint on the field, shaping future policies and practices for years to come. Dr. Weaver’s unwavering commitment to public health, research excellence, and community advocacy ensures that her influence will continue to grow, inspiring generations of scholars and practitioners to follow in her footsteps.

 

Publications

  • 📄 Emerging Virtual Reality Technologies and Opportunities for Public Health Programming
    Authors: Nancy Weaver, Kimberly Pryor
    Journal: Evaluation and Program Planning
    Year: 2025

  • 📄 Evaluation of Support Over Silence for KIDS: A Bystander Training Program to Address Public Child Maltreatment
    Authors: Meghan E. Taylor, Nancy L. Weaver, Terri L. Weaver, Travis M. Loux, Timothy J. Kutz
    Journal: Journal of Family Violence
    Year: 2023

  • 📄 Addressing caregiver-child conflict in public: Barriers and facilitators to bystander engagement
    Authors: Vithya Murugan, Terri L. Weaver, Meghan E. Taylor, Nancy L. Weaver, Allie D. Conlon
    Journal: Journal of Family Trauma, Child Custody and Child Development
    Year: 2021

  • 📄 Support Over Silence for KIDS: A bystander training program to address public child maltreatment
    Authors: Nancy L. Weaver, Meghan E. Taylor, Terri L. Weaver, Timothy J. Kutz
    Journal: Children and Youth Services Review
    Year: 2020

  • 📄 Unintentional child injury in child welfare placements
    Authors: Jesse J. Helton, Nancy L. Weaver
    Journal: Child Abuse and Neglect
    Year: 2020

 

Panupong Hansrivijit | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Panupong Hansrivijit | Health Professions | Best Researcher Award

Brigham and Women's Hospital | United States

Author Profile

Scopus

Orcid

Google Scholar

🌟 Early Academic Pursuits

Dr. Panupong Hansrivijit embarked on his medical journey at Chulalongkorn University, where he graduated with first-class honors in medicine. His passion for internal medicine and nephrology led him to pursue an internship at Thammasat University Hospital, where he gained extensive clinical experience in patient care and medical procedures. This strong academic foundation set the stage for his future endeavors in nephrology research and clinical excellence.

🏥 Professional Endeavors

Dr. Hansrivijit’s medical career took him to the United States, where he completed his Internal Medicine Residency at UPMC Harrisburg. This period was crucial in shaping his skills in patient diagnosis, management, and research methodologies. Currently, he is a Nephrology Fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, specializing in managing complex kidney disorders, dialysis, and transplantation. Simultaneously, he is advancing his expertise in public health through a Master of Public Health (MPH) at Harvard T.H. Chan School of Public Health.

🔬 Contributions and Research Focus

Dr. Hansrivijit has made significant contributions to the field of nephrology, particularly in chronic kidney disease, dialysis, kidney transplantation, and pharmaco-epidemiology. His research spans multiple areas, including machine learning applications in kidney disease prediction, outcomes of kidney transplant recipients, and the impact of metabolic disorders on renal health. His extensive list of publications reflects his dedication to evidence-based medicine and improving patient outcomes.

🏆 Accolades and Recognition

Dr. Hansrivijit's groundbreaking work has earned him multiple prestigious awards, including the Best Researcher Award (2025) from both the International Environmental Awards and the International Invention Awards. His achievements also include multiple Kidney STARS Program Awards from the American Society of Nephrology, a Travel Grant Award from the International Society of Nephrology, and recognition for his contributions to global nephrology research.

🌍 Impact and Influence

Beyond his clinical and research work, Dr. Hansrivijit is an active member of the nephrology community, holding memberships in renowned organizations such as the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN). His contributions in meta-analyses, systematic reviews, and nephrology-based epidemiological research have influenced treatment strategies and policy discussions on kidney disease management worldwide.

🚀 Legacy and Future Contributions

With a growing portfolio of influential research and clinical expertise, Dr. Hansrivijit is set to become a leader in nephrology innovation. His future contributions will likely focus on improving dialysis techniques, optimizing transplant outcomes, and utilizing data-driven methodologies to enhance patient care. His dedication to advancing kidney health and public health policies ensures that his impact will be felt for generations to come.

Publications

  • 📄 Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States
    Author(s): Panupong Hansrivijit, Helen Tesfaye, Deborah J. Wexler, Elisabetta Patorno, Julie M. Paik
    Journal: Journal of Clinical Medicine
    Year: 2025

  • 📄 A Hospice Transitions Program for Patients in the Emergency Department
    Author(s): Christopher William A. Baugh, Kei Ouchi, Jason K. Bowman, Elizabeth M. Rickerson, Mallika Lakshmi Mendu
    Journal: JAMA Network Open
    Year: 2024

  • 📄 Unpacking Contributors to CKD Incidence and Progression: Time to Move Beyond Traditional Risk Factors
    Author(s): Panupong Hansrivijit, Lipika Samal, Mallika Lakshmi Mendu
    Journal: American Journal of Kidney Diseases
    Year: 2023

  • 📄 Hepatitis E Virus Infection in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
    Author(s): Angkawipa Trongtorsak, Natapat Chaisidhivej, Kritika Yadav, Wisit Cheungpasitporn, Panupong Hansrivijit
    Journal: Journal of Investigative Medicine
    Year: 2022

  • 📄 Renal Manifestations of Hepatitis E Among Immunocompetent and Solid Organ Transplant Recipients
    Author(s): Karthik Reddy Kovvuru, Nicholas Carbajal, Abhinandan Reddy Pakanati, Wisit Cheungpasitporn, Swetha Rani Kanduri
    Journal: World Journal of Hepatology
    Year: 2022

 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022

 

Chansokhon Ngan | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Mr. Chansokhon Ngan | Medicine and Dentistry | Best Researcher Award

West China Hospital of Sichuan University | China

Author Profile

Orcid

Early Academic Pursuits

Mr. Chansokhon Ngan embarked on his academic journey with a fervent dedication to advancing knowledge in critical care medicine. As a PhD student specializing in Critical Care Medicine at West China Hospital of Sichuan University, he cultivated a strong foundation in research methodologies, data analysis, and clinical practice. His academic pursuits equipped him with the necessary skills to address complex clinical challenges and contribute meaningfully to patient care and medical research.

Professional Endeavors

Throughout his career, Mr. Ngan has been committed to advancing knowledge in critical care medicine through his research endeavors. One of his notable studies, titled "Cardiac index and heart rate as prognostic indicators for mortality in septic shock: A retrospective cohort study from the MIMIC-IV," exemplifies his dedication to excellence in research. Published in Heliyon Journal, this study investigated the relationship between cardiac index (CI), heart rate (HR), and mortality in septic shock patients, utilizing sophisticated data analysis techniques.

Contributions and Research Focus

Mr. Ngan's research focus revolves around critical illnesses, such as septic shock and acute respiratory distress syndrome (ARDS). His contributions to the field include studies on prognostic indicators for mortality in septic shock and predicting the early incidence and stratification of ARDS. Additionally, he is engaged in investigating the application of critical care ultrasound in managing acute respiratory and circulatory dysfunction, aiming to enhance clinical practices and improve patient outcomes.

Accolades and Recognition

Mr. Ngan's dedication to excellence in research has earned him recognition in the medical community. His study on prognostic indicators for mortality in septic shock, published in Heliyon Journal, showcases his commitment to advancing knowledge in critical care medicine. His contributions have been acknowledged for their implications for clinical practice and patient care.

Impact and Influence

Mr. Ngan's research endeavors have made a significant impact on the field of critical care medicine. By investigating prognostic indicators for mortality in septic shock and exploring the application of critical care ultrasound, he has contributed valuable insights that have the potential to improve patient outcomes and enhance clinical practices. His work has influenced the way healthcare providers monitor and manage critical illnesses, leading to more informed decision-making and improved patient care.

Legacy and Future Contributions

As Mr. Ngan continues his academic journey, he remains dedicated to making meaningful contributions to the field of critical care medicine. His research legacy encompasses a commitment to excellence, innovation, and improving patient outcomes. Through his ongoing endeavors, he aims to advance knowledge in critical care medicine, ultimately leaving a lasting impact on the field and paving the way for enhanced clinical practices and patient care.

Notable Publications

Cardiac index and heart rate as prognostic indicators for mortality in septic shock: A retrospective cohort study from the MIMIC-IV database 2024